Fiduciary Group LLC Eli Lilly & CO Transaction History

Fiduciary Group LLC

  • $971 Million
  • Q3 2024

A detailed history of Fiduciary Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fiduciary Group LLC holds 7,222 shares of LLY stock, worth $5.74 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
7,222
Previous 7,152 0.98%
Holding current value
$5.74 Million
Previous $6.48 Million 1.19%
% of portfolio
0.66%
Previous 0.71%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$772.14 - $960.02 $54,049 - $67,201
70 Added 0.98%
7,222 $6.4 Million
Q2 2024

Aug 08, 2024
SELL
$724.87 - $909.04 $118,878 - $149,082
-164 Reduced 2.24%
7,152 $6.48 Million
Q1 2024

May 13, 2024
BUY
$592.2 - $792.28 $104,227 - $139,441
176 Added 2.46%
7,316 $5.69 Million
Q4 2023

Feb 05, 2024
SELL
$525.19 - $619.13 $78,778 - $92,869
-150 Reduced 2.06%
7,140 $4.16 Million
Q3 2023

Nov 13, 2023
SELL
$434.7 - $599.3 $130,410 - $179,790
-300 Reduced 3.95%
7,290 $3.92 Million
Q2 2023

Jul 27, 2023
SELL
$350.74 - $468.98 $12,626 - $16,883
-36 Reduced 0.47%
7,590 $3.56 Million
Q1 2023

May 15, 2023
SELL
$310.63 - $364.82 $15,531 - $18,241
-50 Reduced 0.65%
7,626 $2.62 Million
Q1 2023

May 15, 2023
SELL
$310.63 - $364.82 $11,182 - $13,133
-36 Reduced 0.47%
7,590 $2.61 Million
Q4 2022

Feb 07, 2023
SELL
$321.55 - $374.67 $91,963 - $107,155
-286 Reduced 3.59%
7,676 $2.81 Million
Q3 2022

Nov 14, 2022
BUY
$296.48 - $337.87 $80,642 - $91,900
272 Added 3.54%
7,962 $2.94 Million
Q2 2022

Aug 12, 2022
BUY
$278.73 - $327.27 $278 - $327
1 Added 0.01%
7,690 $2.49 Million
Q1 2022

May 13, 2022
BUY
$234.69 - $291.66 $3,050 - $3,791
13 Added 0.17%
7,689 $2.2 Million
Q4 2021

Feb 14, 2022
SELL
$224.85 - $279.04 $33,727 - $41,856
-150 Reduced 1.92%
7,676 $2.12 Million
Q3 2021

Oct 27, 2021
SELL
$221.6 - $272.71 $60,940 - $74,995
-275 Reduced 3.39%
7,826 $1.94 Million
Q2 2021

Aug 05, 2021
SELL
$180.55 - $233.54 $13,541 - $17,515
-75 Reduced 0.92%
8,101 $2.13 Million
Q1 2021

May 03, 2021
SELL
$164.32 - $212.72 $16,596 - $21,484
-101 Reduced 1.22%
8,176 $1.49 Million
Q4 2020

Feb 12, 2021
SELL
$130.46 - $172.63 $26,092 - $34,526
-200 Reduced 2.36%
8,277 $1.68 Million
Q2 2020

Aug 14, 2020
BUY
$136.42 - $164.18 $13,641 - $16,418
100 Added 1.19%
8,477 $1.39 Million
Q1 2020

May 11, 2020
SELL
$119.05 - $147.35 $12,381 - $15,324
-104 Reduced 1.23%
8,377 $1.16 Million
Q4 2019

Feb 14, 2020
SELL
$106.92 - $132.43 $15,503 - $19,202
-145 Reduced 1.68%
8,481 $1.12 Million
Q3 2019

Nov 13, 2019
SELL
$106.79 - $116.16 $134,768 - $146,593
-1,262 Reduced 12.76%
8,626 $964,000
Q2 2019

Aug 05, 2019
SELL
$110.79 - $129.32 $46,864 - $54,702
-423 Reduced 4.1%
9,888 $1.1 Million
Q1 2019

May 08, 2019
SELL
$111.31 - $131.02 $5,008 - $5,895
-45 Reduced 0.43%
10,311 $1.34 Million
Q4 2018

Feb 13, 2019
SELL
$105.9 - $118.64 $47,125 - $52,794
-445 Reduced 4.12%
10,356 $1.2 Million
Q3 2018

Oct 18, 2018
BUY
$85.86 - $107.31 $11,161 - $13,950
130 Added 1.22%
10,801 $1.16 Million
Q2 2018

Aug 02, 2018
SELL
$75.7 - $86.88 $80,620 - $92,527
-1,065 Reduced 9.07%
10,671 $911,000
Q1 2018

May 14, 2018
SELL
$74.21 - $87.6 $26,196 - $30,922
-353 Reduced 2.92%
11,736 $908,000
Q4 2017

Feb 02, 2018
SELL
$81.94 - $87.89 $28,023 - $30,058
-342 Reduced 2.75%
12,089 $1.02 Million
Q3 2017

Nov 13, 2017
BUY
$77.07 - $85.54 $958,057 - $1.06 Million
12,431
12,431 $1.06 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fiduciary Group LLC Portfolio

Follow Fiduciary Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email